Amino acid transmitters and cations were assessed in the frontal cortex and hippocampus of 12 Alzheimer's disease (AD), 4 multi-infarct dementia (MID) patients, and 12 age-matched controls. In the hippocampus, but not in the frontal cortex of AD patients we observed an increase of sodium (Na) and a decrease of potassium (K) and magnesium (Mg) content as compared to controls. Calcium (Ca) was not changed. These cation shifts were highly correlated with glutamate, which was significantly decreased in AD hippocampus. Hippocampal Na and K levels correlated also highly with gamma-aminobutyrate, cholineacetyltransferase and noradrenaline levels in the hippocampus and dementia scores. These results show that Na and K changes are sensitive markers ...
Glutamate is the major transmitter of the brain and is involved in all aspects of cognitive function...
Changes in metabolites detected by proton magnetic resonance spectroscopy (1H MRS) of the brain have...
Abstract. Indirect evidence supports altered glutamate signaling with Alzheimer’s disease, however, ...
Amino acid transmitters and cations were assessed in the frontal cortex and hippocampus of 12 Alzhei...
Glutamate or a related excitatory amino acid is thought to be the major excitatory neurotransmitter ...
AbstractAlzheimer's disease (AD) is associated with impaired glutamate clearance and depressed Na+/K...
The concentrations of selected metabolites in the hippocampus and cerebellum of 13 Alzheimer's ...
Alzheimer's disease (AD) is associated with significant disturbances in the homeostasis of Na+ and K...
Vascular dementia (VaD) is thought to be the second most common cause of age-related dementia amongs...
Proton magnetic resonance spectroscopy (H-1-MRS) studies have previously reported reduced brain N-ac...
The cations, calcium, magnesium, sodium, and potassium, putative amino acid transmitters, and total ...
Early Alzheimer's disease (AD) is characterized by memory loss and hippocampal atrophy with relative...
Early Alzheimer's disease (AD) is characterized by memory loss and hippocampal atrophy with rel...
Glutamate is a major excitatory neurotransmitter that has been implicated in memory formation and le...
Abstract Prior studies have reported hippocampal volume loss, decrease in N-Acetylaspartate (NAA) co...
Glutamate is the major transmitter of the brain and is involved in all aspects of cognitive function...
Changes in metabolites detected by proton magnetic resonance spectroscopy (1H MRS) of the brain have...
Abstract. Indirect evidence supports altered glutamate signaling with Alzheimer’s disease, however, ...
Amino acid transmitters and cations were assessed in the frontal cortex and hippocampus of 12 Alzhei...
Glutamate or a related excitatory amino acid is thought to be the major excitatory neurotransmitter ...
AbstractAlzheimer's disease (AD) is associated with impaired glutamate clearance and depressed Na+/K...
The concentrations of selected metabolites in the hippocampus and cerebellum of 13 Alzheimer's ...
Alzheimer's disease (AD) is associated with significant disturbances in the homeostasis of Na+ and K...
Vascular dementia (VaD) is thought to be the second most common cause of age-related dementia amongs...
Proton magnetic resonance spectroscopy (H-1-MRS) studies have previously reported reduced brain N-ac...
The cations, calcium, magnesium, sodium, and potassium, putative amino acid transmitters, and total ...
Early Alzheimer's disease (AD) is characterized by memory loss and hippocampal atrophy with relative...
Early Alzheimer's disease (AD) is characterized by memory loss and hippocampal atrophy with rel...
Glutamate is a major excitatory neurotransmitter that has been implicated in memory formation and le...
Abstract Prior studies have reported hippocampal volume loss, decrease in N-Acetylaspartate (NAA) co...
Glutamate is the major transmitter of the brain and is involved in all aspects of cognitive function...
Changes in metabolites detected by proton magnetic resonance spectroscopy (1H MRS) of the brain have...
Abstract. Indirect evidence supports altered glutamate signaling with Alzheimer’s disease, however, ...